Cost and access to weight-loss drugs While highly effective, GLP-1 medications come at a steep priceup to $1,349 per month, often only partially covered by insurance
References Zinman B, et al
Estos medicamentos incluyen semaglutida (Ozempic, Wegovy, Rybelsus), dulaglutida (Trulicity), liraglutida (Victoza, Saxenda) y exenatida de liberacin extendida (Bydureon BCise), entre otros
Lega, I
Analizy farmakoekonomiczne sugeruj, e u wybranych pacjentw (z wysokim ryzykiem sercowym) koszty mog si zwrci poprzez uniknite zaway/udary (Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists: Exploring Their Impact on Diabetes, Obesity, and Cardiovascular Health Through a Comprehensive Literature Review PMC) (Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists: Exploring Their Impact on Diabetes, Obesity, and Cardiovascular Health Through a Comprehensive Literature Review PMC), ale u innych grup opacalno jest wtpliwa
Weight loss from GLP-1 agonists can reduce AHI, potentially allowing for lower CPAP pressures or, in some cases, resolution of mild OSA